Excellence Emerging Investigator Grant within Endocrinology and Metabolism – Nordic Region supports starting research leaders studying endocrine and metabolic disease to advance understanding, treatment, and prevention.
Funder: Novo Nordisk Foundation
Due Dates: January 19, 2027, 2:00 pm Copenhagen time (Full application)
Funding Amounts: Up to DKK 12.5 million over five years (approximately DKK 2.5 million annually)
Summary: Supports starting research leaders establishing independent teams to advance understanding, treatment, and prevention of endocrine and metabolic disease.
Key Information: Applicants must be employed at, and maintain their primary research group and project at, a Nordic nonprofit research institution.
The Novo Nordisk Foundation supports promising starting group leaders conducting ambitious basic and clinical research in endocrinology and metabolism. Part of its Research Leader Programme, the grant promotes Nordic research at a high international level while helping investigators develop their leadership and establish independent teams.
The scientific scope includes cellular energy homeostasis and hormonal disorders across all endocrine subfields, including diabetes, thyroid disorders, reproduction, and bone and calcium metabolism. Supported approaches include patient and clinical research, animal models, model organisms, cellular or subcellular systems with clear whole-body relevance, and in silico analysis. Cancer research is excluded, although endocrine tumour projects focused on signalling or crosstalk rather than cancer development may be considered.